Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.08 USD | -0.45% | -6.54% | +76.10% |
05-08 | Transcript : Y-mAbs Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
05-07 | Earnings Flash (YMAB) Y-MABS THERAPEUTICS Posts Q1 Revenue $19.9M, vs. Street Est of $22.2M | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+76.10% | 533M | |
+9.26% | 115B | |
+9.96% | 105B | |
-12.55% | 22.71B | |
+3.09% | 21.83B | |
-10.72% | 18.18B | |
-41.92% | 16.52B | |
-16.11% | 16.01B | |
+1.51% | 14.14B | |
+17.64% | 10.71B |
- Stock Market
- Equities
- YMAB Stock
- News Y-mAbs Therapeutics, Inc.
- Transcript : Y-mAbs Therapeutics, Inc., 2021 Earnings Call, Feb 25, 2022